This article is more than 5 years old. Information may no longer be current.
Top 5 gastroenterology stories in September
Click Here to Manage Email Alerts
Healio Gastroenterology and Liver Disease has compiled a list of the top five gastroenterology stories posted in September.
Readers were interested in the FDA’s marketing approval of a new device, the reduction of IBS symptoms with the aid of antidepressants, and more.
FDA clears new device to aid slim colonoscopy procedures
The FDA issued 501(k) clearance to Motus GI Holdings Inc. for the commercialization of a novel device that is compatible with smaller diameter and more flexible slim colonoscopes with additional enhancements to Motus’ low friction lubricious coating technology to aid in navigation through the colon. READ MORE
Vedolizumab combination therapy helps UC patients avoid colectomy
More than two-thirds of patients with ulcerative colitis treated with a calcineurin inhibitor in combination with Entyvio experienced colectomy-free survival for a year, according to research published in Clinical Gastroenterology and Hepatology. READ MORE
Antidepressants, psychological therapies reduce IBS symptoms
Antidepressants can help reduce symptoms of irritable bowel syndrome by targeting the interaction between the brain and the gut, according to a meta-analysis published in The American Journal of Gastroenterology. READ MORE
Steroid injection helps prevent strictures after esophageal dilation
A steroid injection immediately after endoscopic balloon dilation helped patients avoid refractory esophageal strictures, according to research published in the American Journal of Gastroenterology. READ MORE
Probiotics help reduce pediatric antibiotic use
Taking probiotics to reduce the risk for common acute infections might also be linked with a reduction in antibiotic use among children and infants, according to a meta-analysis published in the European Journal of Public Health. READ MORE